🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

💦 Restricting IV fluids in adults with septic shock in #ICU: analysis of CLASSIC trial. Restriction resulted in similar survival, HRQoL, cognitive function at 1 year vs standard therapy but clinically important differences could not be ruled out #FOAMcc 🖇️rdcu.be/deP7j

Congratulations Auckland Hospital for recruiting the 250th patient. We have now reached 25% of our recruitment target. Thanks to all the sites that have contributed so far.

Congratulations to Fiona Stanley Hospital in Perth for enrolling their first patient into the trial ACEM ANZICS Clinical Trials Group anzicrc

Congratulations to Ipswitch! First 2 patients in 2 days! ACEM ANZICS Clinical Trials Group anzicrc

Resuscitation practices in patients presenting to the ED with early #sepsis doi.org/10.1111/1742-6… ARISE Fluids RCT Sandra Peake A/Prof Naomi Hammond Serena Knowles Stephen Macdonald Wiley Clinical Health ACEM

IV fluid and vasopressor use among patients with sepsis and septic shock admitted to ICU from ED in Australia and New Zealand - a point prevalence study onlinelibrary.wiley.com/doi/10.1111/17… ARISE Fluids RCT ANZICS Clinical Trials Group The George Institute for Global Health

Congratulations to Westmead Hospital for enrolling their first patient into the trial ANZICS Clinical Trials Group ACEM anzicrc

Acknowledging our two new sites in Aotearoa New Zealand, Wellington and Dunedin Hospitals, who have both recently recruited their first participants ANZICS Clinical Trials Group ACEM MRINZ - Medical Research Institute of New Zealand

ARISE FLUIDS is evaluating the comparative effectiveness and safety of two approaches to hemodynamic resuscitation in ED patients with septic shock. Check out out the infographic for a summary of the trial ⁦ACEM⁩ ⁦ANZICS Clinical Trials Group⁩ ⁦anzicrc⁩

Around 10k people die of #sepsis each year across Australia and Aotearoa New Zealand ARISE Fluids RCT is trying to reduce the burden of sepsis in our community through research Sepsis Australia MRINZ - Medical Research Institute of New Zealand anzicrc ANZICS Clinical Trials Group ACEM Global Sepsis Alliance (GSA)

Congratulations to Royal Darwin and Palmerston Hospital for recruiting the 400th trial participant ANZICS Clinical Trials Group ACEM anzicrc

Congratulations ANZICS Clinical Trials Group endorsed trials. TEAM ACTA trial of the year and Suddicu study runner up.

Recruitment of the 600th trial participant. Many thanks to the Royal Perth Hospital team Centre for Clinical Research in Emergency Medicine Harry Perkins Institute UWA Research ANZICS Clinical Trials Group ACEM anzicrc

Introducing the 1️⃣3️⃣ track cyclists selected for the #Paris2024 Olympic Games! 🚴🏼 #AllezAUS | AusCycling | ARA Australian Cycling Team

Chloe Moran is off to her first The Olympic Games 🇦🇺 #AllezAUS #Paris2024

We have recruited 750/1000 participants in the trial. Thanks Port Macquarie Base Hospital. On the home stretch towards completion. Thanks to all our participating sites and investigators ACEM ANZICS Clinical Trials Group anzicrc

We can’t wait to share the results of the TARGET Protein trial- the largest trial of augment protein in critically ill adults!

Big shout out to Ipswich Hospital for enrolling participant number 800. Great work team anzicrc ANZICS Clinical Trials Group ACEM

Augmenting enteral protein did not improve outcomes for critically ill patients compared with standard protein levels in the intensive care setting. #CCR25 Critical Care Reviews ja.ma/45jf3NI

Very proud to be here as part of the TARGET Protein study team and support A/Prof Lee-anne Chapple Adam Matthew Deane and Matt Summers Sandra Peake Augmented Enteral Protein During Critical Illness jamanetwork.com/journals/jama/… #CCR25